Literature DB >> 16045827

Clinical trials in giant cell arteritis.

Luis R Espinoza1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16045827     DOI： 10.1007/s11926-005-0034-7

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  5 in total

Review 1.  Low-dose aspirin in the treatment of giant cell arteritis.

Authors:  David B Hellmann
Journal:  Arthritis Rheum       Date:  2004-04

2.  Therapeutic effects of acetylsalicylic acid in giant cell arteritis.

Authors:  Cornelia M Weyand; Markus Kaiser; Hongyu Yang; Brian Younge; Jörg J Goronzy
Journal:  Arthritis Rheum       Date:  2002-02

3.  Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision.

Authors:  G T Liu; J S Glaser; N J Schatz; J L Smith
Journal:  Ophthalmology       Date:  1994-11       Impact factor: 12.079

4.  Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.

Authors:  Gideon Nesher; Yaakov Berkun; Michal Mates; Mario Baras; Alan Rubinow; Moshe Sonnenblick
Journal:  Arthritis Rheum       Date:  2004-04

5.  Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.

Authors:  M A González-Gay; R Blanco; V Rodríguez-Valverde; V M Martínez-Taboada; M Delgado-Rodriguez; M Figueroa; E Uriarte
Journal:  Arthritis Rheum       Date:  1998-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.